LYNBROOK, N.Y., Nov. 3, 2009 (GLOBE NEWSWIRE) -- IPOdesktop.com, in a continuation of its Internet radio interviews featuring BioSpecifics Technologies Corp. (Nasdaq:BSTC), today features an interview with Dr. Eugene Wolf. Dr.... [read full story]
|
RELATED
|
|
LYNBROOK, N.Y., Nov. 5 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the...
LYNBROOK, N.Y., Nov. 5 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. , a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the third quarter...
BioSpecifics Technologies Corp. , a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the third quarter ended September 30, 2009.
LYNBROOK, N.Y., Nov. 3, 2009 (GLOBE NEWSWIRE) -- IPOdesktop.com, in a continuation of its Internet radio interviews featuring BioSpecifics Technologies Corp. (Nasdaq:BSTC - News), today features an interview with Dr. Eugene...
LYNBROOK, N.Y., Nov. 3, 2009 (GLOBE NEWSWIRE) -- IPOdesktop.com, in a continuation of its Internet radio interviews featuring BioSpecifics Technologies Corp. (Nasdaq:BSTC), today features an interview with Dr. Eugene Wolf. Dr....
Entertainment and lifestyle, General Hospitals, Hospital Care, Health Care, Radio, Surgery, Auxilium Pharmaceuticals, Pfizer, Aquitaine, Gironde, Bordeaux, France
